Bupropion: Risks and benefits

Expert Opinion on Drug Safety

Volumn 4, Issue 6, 2005, Pages 995-1003

  Ross, Sarah ^a   Williams, David ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bupropion; Health economics; Nicotine; Smoking cessation

Indexed keywords

ALCOHOL; AMANTADINE; AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; BUSPIRONE; CARBAMAZEPINE; CARBON MONOXIDE; CIGARETTE SMOKE; CLONIDINE; DESIPRAMINE; HYDROGEN CYANIDE; IMIPRAMINE; LEVODOPA; LOBELINE; MECAMYLAMINE; METOPROLOL; NALOXONE; NICOTINE; NICOTINE DERIVATIVE; NICOTINE GUM; NITROGEN OXIDE; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; PLACEBO; RISPERIDONE; TAR; THIORIDAZINE; UNINDEXED DRUG; VALPROIC ACID;

ABDOMINAL PAIN; ACUPUNCTURE; ADJUVANT THERAPY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANXIETY DISORDER; ARTHRALGIA; BEHAVIOR THERAPY; BRONCHOSPASM; CIGARETTE SMOKING; CLINICAL TRIAL; CONFUSION; CONSTIPATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEATH; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG TOLERABILITY; GROUP THERAPY; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; HYPNOSIS; INSOMNIA; MAXIMUM PERMISSIBLE DOSE; META ANALYSIS; MOTIVATION; MYALGIA; NAUSEA; NICOTINE REPLACEMENT THERAPY; NOSE IRRITATION; PASSIVE SMOKING; PATIENT COMPLIANCE; PRURITUS; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; SKIN IRRITATION; SMOKING CESSATION; STEVENS JOHNSON SYNDROME; STROKE; SUICIDAL BEHAVIOR; SWEATING; SYSTEMATIC REVIEW; THORAX PAIN; TOBACCO DEPENDENCE; URTICARIA; VOMITING; XEROSTOMIA;

BUPROPION; COST-BENEFIT ANALYSIS; DOPAMINE UPTAKE INHIBITORS; HUMANS; SEIZURES; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 27944490477     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.6.995     Document Type: Review

References (40)

1. JORENBY D: Clinical efficacy of bupropion in the management of smoking cessation. Drugs (2002) 62(Suppl. 2):25-35.
2. DOLL R, PETO R, BOREHAM J, SUTHERLAND I: Mortality in relation to smoking: 50 years' observations on male British doctors. Br. Med. J. (2004) 328:1519.
3. EDWARDS R: The problem of tobacco smoking. Br. Med. J. (2004) 328:217-219.
4. NATIONAL INSTITUTE OF CLINICAL EXCELLENCE: Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. NICE report (2002) No. 39.
5. NO AUTHORS LISTED: A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA (2000) 283:3244-3254.
6. FAGERSTROM K: The epidemiology of smoking: health consequences and benefits of cessation. Drugs (2002) 62(Suppl. 2):1-9.
7. HAYS JT, EBBERT JO: Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs (2003) 17:71-83.
8. LIGHTWOOD JM, PHIBBS CS, GLANTZ SA: Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics (1999) 104:1312-1320.
9. LIGHTWOOD JM, GLANTZ SA: Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation (1997) 96:1089-1096.
10. WARING WS: The role of pharmacotherapy in assisting smoking cessation. Eur. J. Clin. Pharmacol. (2003) 59:351-356.
11. SILAGY C, STEAD LF: Physician advice for smoking cessation. Cochrane Database Syst. Rev. (2004) (4):CD000165.
12. LANCASTER T, STEAD LF: Individual behavioural counselling for smoking cessation. Cochrane Database Syst. Rev. (2005) (2):CD001292.
13. RICE VE, STEAD LF: Nursing interventions for smoking cessation. Cochrane Database Syst. Rev. (2004) (1):CD001188.
14. SUTHERLAND G: Current approaches to the management of smoking cessation. Drugs (2002) 62(Suppl. 2):53-61.
15. WHITE AR, RAMPES H, ERNST E: Acupuncture for smoking cessation. Cochrane Database Syst. Rev. (2002) (2):CD000009.
16. SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (2004) (3):CD000146.
17. HUGHES JR, STEAD LF, LANCASTER T: Antidepressants for smoking cessation. Cochrane Database Syst. Rev. (2004) (4):CD000031.
18. GOURLAY SG, STEAD LF, BENOWITZ NL. Clonidine for smoking cessation. Cochrane Database Syst. Rev. (2004) (3):CD000058.
19. HOLM KJ, SPENCER CM: Bupropion: a review of its use in the management of smoking cessation. Drugs (2000) 59:1007-1024.
20. BALFOUR DJ: The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int. J. Clin. Pract. (2001) 55:53-57.
21. JOHNSTON AJ, ASCHER J, LEADBETTER R et al.: Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation. Drugs (2002) 62(Suppl. 2):11-24.
22. TASHKIN D, KANNER R, BAILEY W et al.: Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 357:1571-1575.
23. HURT RD, SACHS DP, GLOVER ED et al.: A comparison of sustained-release bupropion and placebo for smoking cessation. NEJM (1997) 337:1195-1202.
24. TONSTAD S, FARSANG C, KLAENE G et al.: Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur. Heart J. (2003) 24:946-955.
25. HALL SM, HUMFLEET GL, REUS VI, MUNOZ RF, HARTZ DT, MAUDE-GRIFFIN R: Psychological intervention and antidepressant treatment in smoking cessation. Arch. Gen. Psychiatry (2002) 59:930-936.
26. JORENBY DE, LEISCHOW SJ, NIDES MA et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. NEJM (1999) 340:685-691.
27. HAYS JT, HURT RD, RIGOTTI NA, NIAURA R et al.: Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomised, controlled trial. Ann. Intern. Med. (2001) 135:423-433.
28. CHENGAPPA KN, KAMBHAMPATI RK, PERKINS K et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants. J. Clin. Psychiatry (2001) 62:503-508.
29. HAYFORD KE, PATTEN CA, RUMMANS TA et al.: Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br. J. Psychiatry (1999) 174:173-178.
30. HERTZBERG MA, MOORE SD, FELDMAN ME, BECKHAM JC: A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J. Clin. Psychopharmacol. (2001) 21:94-98.
31. EVINS AE, MAYS VK, RIGOTTI NA, TISDALE T, CATHER C, GOFF DC: A pilot trial of bupropion added to cognitive behavioural therapy for smoking cessation in schizophrenia. Nicotine Tob. Res. (2001) 3:397-403.
32. WEINER E, BALL MP, SUMMERFELT A, GOLD J, BUCHANAN RW: Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am. J. Psychiatry (2001) 158:635-637.
33. HAYS JT: Tobacco dependence treatment in patients with heart and lung disease: implications for intervention and review of pharmacological therapy. J. Cardiopulmon rehabil. (2000) 20:215-223.
34. ASCHER JA, COLE JO, COLIN JN, FEIGHNER JP, FERRIS RM, FIBIGER HC et al.: Bupropion: a review of its mechanism of antidepressant activity. J. Clin Psychiatry (1995) 56:395-401.
35. BOSHIER A, WILTON LV, SHAKIR SA: Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000. Eur. J. Clin Pharmacol. (2003) 59:767-773.
36. AUBIN HJ: Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs (2002) 62(Suppl. 2):45-52.
37. COMMITTEE ON SAFETY OF MEDICINES: Zyban (bupropion) - safety reminder. Curr. Prob. Pharmacovig. (2001) 27:5.
38. GODFREY C, FOWLER G: Pharmacoeconomic considerations in the management of smoking cessation. Drugs (2002) 62(Suppl. 2):63-70.
39. PARROTT S, GODFREY C: Economics of smoking cessation. Br. Med. J. (2004) 328:947-949.
40. BARENDREGT JJ, BONNEUX L, VAN DER MAAS PJ: The health care costs of smoking. NEJM (1997) 337:1052-1057.